Hematología Traslacional
NavarraBiomed
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de NavarraBiomed (9)
2024
-
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
EMBO Molecular Medicine, Vol. 16, Núm. 8, pp. 1791-1816
2023
2022
-
CAR-T Cells for the Treatment of Lung Cancer
Life, Vol. 12, Núm. 4
-
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
Cancers, Vol. 14, Núm. 16
-
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
International Journal of Molecular Sciences, Vol. 23, Núm. 17
-
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
International Journal of Molecular Sciences, Vol. 23, Núm. 17
-
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
Cancers, Vol. 14, Núm. 18
-
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
Frontiers in Oncology, Vol. 12
2020
-
Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction
Circulation, Vol. 142, Núm. 19, pp. 1831-1847